{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:18:13Z","timestamp":1785889093092,"version":"3.56.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.biocel.2013.07.016","type":"journal-article","created":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T05:02:41Z","timestamp":1375160561000},"page":"2179-2185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Control of food intake and muscle wasting in cachexia"],"prefix":"10.1016","volume":"45","author":[{"given":"Marie","family":"Amitani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Asakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Amitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Inui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2013.07.016_bib0005","first-page":"401","article-title":"Cytokines in the pathogenesis of cancer cachexia","volume":"6","author":"Argiles","year":"2003","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1016\/j.biocel.2013.07.016_bib0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1517\/14712598.2013.727390","article-title":"The potential of ghrelin in the treatment of cancer cachexia","volume":"13","author":"Argiles","year":"2013","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1016\/j.biocel.2013.07.016_bib0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1006961919775","article-title":"Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia","volume":"26","author":"Attaix","year":"1999","journal-title":"Molecular Biology Reports"},{"key":"10.1016\/j.biocel.2013.07.016_bib0020","doi-asserted-by":"crossref","first-page":"R893","DOI":"10.1152\/ajpregu.00015.2008","article-title":"Ghrelin inhibits skeletal muscle protein breakdown in rats with thermal injury through normalizing elevated expression of E3 ubiquitin ligases MuRF1 and MAFbx","volume":"296","author":"Balasubramaniam","year":"2009","journal-title":"American Journal of Physiology \u2013 Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.biocel.2013.07.016_bib0025","first-page":"237","article-title":"Hypercatabolism and hypermetabolism in wasting states","volume":"5","author":"Baracos","year":"2002","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1016\/j.biocel.2013.07.016_bib0030","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0899-9007(01)00631-1","article-title":"Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation","volume":"17","author":"Barber","year":"2001","journal-title":"Nutrition"},{"key":"10.1016\/j.biocel.2013.07.016_bib0035","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/14728222.9.4.737","article-title":"Interleukin-6 and new strategies for the treatment of cancer, hyperproliferative diseases and paraneoplastic syndromes","volume":"9","author":"Barton","year":"2005","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"10.1016\/j.biocel.2013.07.016_bib0040","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nature01388","article-title":"STAT3 signalling is required for leptin regulation of energy balance but not reproduction","volume":"421","author":"Bates","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2013.07.016_bib0045","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1517\/14712598.2011.627850","article-title":"A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer","volume":"11","author":"Bayliss","year":"2011","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1016\/j.biocel.2013.07.016_bib0050","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00520-008-0403-7","article-title":"A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122)","volume":"16","author":"Berk","year":"2008","journal-title":"Supportive Care in Cancer"},{"key":"10.1016\/j.biocel.2013.07.016_bib0055","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.biocel.2013.07.016_bib0060","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"American Journal of Physiology \u2013 Endocrinology and Metabolism"},{"key":"10.1016\/j.biocel.2013.07.016_bib0065","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1245\/s10434-006-9179-5","article-title":"Cancer cachexia: it's time for more clinical trials","volume":"14","author":"Bossola","year":"2007","journal-title":"Annals of Surgical Oncology"},{"key":"10.1016\/j.biocel.2013.07.016_bib0070","first-page":"237","article-title":"Hypothalamic regulation of muscle metabolism","volume":"14","author":"Braun","year":"2011","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1016\/j.biocel.2013.07.016_bib0075","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1084\/jem.20111020","article-title":"Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis","volume":"208","author":"Braun","year":"2011","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.biocel.2013.07.016_bib0080","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1210\/en.2003-0087","article-title":"Cytokine-hormone interactions: tumor necrosis factor alpha impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts","volume":"144","author":"Broussard","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.biocel.2013.07.016_bib0085","doi-asserted-by":"crossref","first-page":"e46893","DOI":"10.1371\/journal.pone.0046893","article-title":"Adipose tissue promotes a serum cytokine profile related to lower insulin sensitivity after chronic central leptin infusion","volume":"7","author":"Burgos-Ramos","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biocel.2013.07.016_bib0090","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.bbagen.2006.09.001","article-title":"Interleukin-15 increases glucose uptake in skeletal muscle. An antidiabetogenic effect of the cytokine","volume":"1760","author":"Busquets","year":"2006","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.biocel.2013.07.016_bib0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jamda.2010.02.012","article-title":"Phase II study of the novel peptide-nucleic acid OHR118 in the management of cancer-related anorexia\/cachexia","volume":"12","author":"Chasen","year":"2011","journal-title":"Journal of the American Medical Directors Association"},{"key":"10.1016\/j.biocel.2013.07.016_bib0100","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1210\/endo.141.11.7778","article-title":"Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation","volume":"141","author":"Chesnokova","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.biocel.2013.07.016_bib0105","doi-asserted-by":"crossref","first-page":"F1315","DOI":"10.1152\/ajprenal.00341.2012","article-title":"Melanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease","volume":"303","author":"Cheung","year":"2012","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.biocel.2013.07.016_bib0110","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ki.2008.150","article-title":"Modulation of melanocortin signaling ameliorates uremic cachexia","volume":"74","author":"Cheung","year":"2008","journal-title":"Kidney International"},{"key":"10.1016\/j.biocel.2013.07.016_bib0115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13539-011-0034-6","article-title":"The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial","volume":"2","author":"Dalton","year":"2011","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"key":"10.1016\/j.biocel.2013.07.016_bib0120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1677\/joe.0.1560083","article-title":"Glucocorticoid effects on insulin- and IGF-I-regulated muscle protein metabolism during aging","volume":"156","author":"Dardevet","year":"1998","journal-title":"Journal of Endocrinology"},{"key":"10.1016\/j.biocel.2013.07.016_bib0125","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/en.2007-1046","article-title":"Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile","volume":"149","author":"Deboer","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.biocel.2013.07.016_bib0130","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1210\/en.2007-0016","article-title":"Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia","volume":"148","author":"Deboer","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.biocel.2013.07.016_bib0135","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cyto.2010.05.006","article-title":"Circulating leptin and inflammatory response in esophageal cancer, esophageal cancer-related cachexia-anorexia syndrome (CAS) and non-malignant CAS of the alimentary tract","volume":"51","author":"Diakowska","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.biocel.2013.07.016_bib0140","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(13)70055-X","article-title":"Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial","volume":"14","author":"Dobs","year":"2013","journal-title":"Lancet Oncology"},{"key":"10.1016\/j.biocel.2013.07.016_bib0145","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1182\/blood-2011-12-400051","article-title":"Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia","volume":"119","author":"Eghtedar","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.biocel.2013.07.016_bib0150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0896-6273(00)81084-3","article-title":"From lesions to leptin: hypothalamic control of food intake and body weight","volume":"22","author":"Elmquist","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.biocel.2013.07.016_bib0155","doi-asserted-by":"crossref","first-page":"287457","DOI":"10.1155\/2012\/287457","article-title":"Leptin in anorexia and cachexia syndrome","volume":"2012","author":"Engineer","year":"2012","journal-title":"International Journal of Peptides"},{"key":"10.1016\/j.biocel.2013.07.016_bib0160","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clinical Nutrition"},{"key":"10.1016\/j.biocel.2013.07.016_bib0165","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Fearon","year":"2013","journal-title":"Nature Reviews Clinical Oncology"},{"key":"10.1016\/j.biocel.2013.07.016_bib0170","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1200\/JCO.2005.04.5724","article-title":"Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia","volume":"24","author":"Fearon","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.biocel.2013.07.016_bib0175","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1091\/mbc.e06-05-0402","article-title":"Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells","volume":"18","author":"Filigheddu","year":"2007","journal-title":"Molecular Biology of the Cell"},{"issue":"E-Suppl.","key":"10.1016\/j.biocel.2013.07.016_bib0180","first-page":"E100","article-title":"Alteration of somatotropic function by proinflammatory cytokines","volume":"82","author":"Frost","year":"2004","journal-title":"Journal of Animal Science"},{"key":"10.1016\/j.biocel.2013.07.016_bib0185","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1615\/CritRevOncog.v17.i3.50","article-title":"Efficacy of ghrelin in cancer cachexia: clinical trials and a novel treatment by rikkunshito","volume":"17","author":"Fujitsuka","year":"2012","journal-title":"Critical Reviews in Oncogenesis"},{"key":"10.1016\/j.biocel.2013.07.016_bib0190","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1038\/tp.2011.25","article-title":"Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival","volume":"1","author":"Fujitsuka","year":"2011","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.biocel.2013.07.016_bib0195","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00520-012-1500-1","article-title":"Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study","volume":"21","author":"Garcia","year":"2013","journal-title":"Supportive Care in Cancer"},{"key":"10.1016\/j.biocel.2013.07.016_bib0200","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.biocel.2005.04.018","article-title":"Skeletal muscle hypertrophy and atrophy signaling pathways","volume":"37","author":"Glass","year":"2005","journal-title":"International Journal of Biochemistry and Cell Biology"},{"key":"10.1016\/j.biocel.2013.07.016_bib0205","doi-asserted-by":"crossref","first-page":"14440","DOI":"10.1073\/pnas.251541198","article-title":"Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy","volume":"98","author":"Gomes","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.biocel.2013.07.016_bib0210","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.physbeh.2010.03.011","article-title":"Hypothalamic mechanisms in cachexia","volume":"100","author":"Grossberg","year":"2010","journal-title":"Physiology and Behavior"},{"key":"10.1016\/j.biocel.2013.07.016_bib0215","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1210\/en.2009-1135","article-title":"Arcuate nucleus proopiomelanocortin neurons mediate the acute anorectic actions of leukemia inhibitory factor via gp130","volume":"151","author":"Grossberg","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.biocel.2013.07.016_bib0220","doi-asserted-by":"crossref","first-page":"3427S","DOI":"10.1093\/jn\/134.12.3427S","article-title":"(n-3) fatty acids and cancer therapy","volume":"134","author":"Hardman","year":"2004","journal-title":"Journal of Nutrition"},{"key":"10.1016\/j.biocel.2013.07.016_bib0225","first-page":"2010","article-title":"Rikkunshito and ghrelin","author":"Hattori","year":"2010","journal-title":"International Journal of Peptides"},{"key":"10.1016\/j.biocel.2013.07.016_bib0230","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.bbagen.2008.06.004","article-title":"Branched-chain amino acids and arginine suppress MaFbx\/atrogin-1 mRNA expression via mTOR pathway in C2C12 cell line","volume":"1780","author":"Herningtyas","year":"2008","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.biocel.2013.07.016_bib0235","first-page":"3059","article-title":"Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice","volume":"119","author":"Hu","year":"2009","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.biocel.2013.07.016_bib0240","first-page":"395","article-title":"Cachexia and obesity: two sides of one coin?","volume":"6","author":"Inui","year":"2003","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1016\/j.biocel.2013.07.016_bib0245","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.peptides.2006.11.021","article-title":"Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83-132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice","volume":"28","author":"Joppa","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.biocel.2013.07.016_bib0250","first-page":"233","article-title":"TWEAK and TRAF6 regulate skeletal muscle atrophy","volume":"15","author":"Kumar","year":"2012","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1016\/j.biocel.2013.07.016_bib0255","doi-asserted-by":"crossref","first-page":"8E","DOI":"10.1016\/j.amjcard.2008.02.065","article-title":"Cachexia: common, deadly, with an urgent need for precise definition and new therapies","volume":"101","author":"Lainscak","year":"2008","journal-title":"American Journal of Cardiology"},{"key":"10.1016\/j.biocel.2013.07.016_bib0260","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13539-012-0085-3","article-title":"Effect of ghrelin and its analogues, BIM-28131 and BIM-28125, on the expression of myostatin in a rat heart failure model","volume":"4","author":"Lenk","year":"2013","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"key":"10.1016\/j.biocel.2013.07.016_bib0265","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1016\/j.clnme.2012.07.004","article-title":"Randomized study of the efficacy and safety of SUN11031 (synthetic human ghrelin) in cachexia associated with chronic obstructive pulmonary disease","volume":"7","author":"Levinson","year":"2012","journal-title":"e-SPEN Journal"},{"key":"10.1016\/j.biocel.2013.07.016_bib0270","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/cncr.24917","article-title":"Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study","volume":"116","author":"Lundholm","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.biocel.2013.07.016_bib0275","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clnu.2011.10.005","article-title":"Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib +\/\u2212 megestrol acetate for patients with cancer-related anorexia\/cachexia syndrome","volume":"31","author":"Madeddu","year":"2012","journal-title":"Clinical Nutrition"},{"key":"10.1016\/j.biocel.2013.07.016_bib0280","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2003-031069","article-title":"The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men","volume":"89","author":"Malkin","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.biocel.2013.07.016_bib0285","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00109-009-0547-z","article-title":"Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia","volume":"88","author":"Mantovani","year":"2010","journal-title":"Journal of Molecular Medicine (Berlin)"},{"key":"10.1016\/j.biocel.2013.07.016_bib0290","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/SPC.0b013e32833e4aa5","article-title":"Contribution of anorexia to tissue wasting in cachexia","volume":"4","author":"Molfino","year":"2010","journal-title":"Current Opinion in Supportive and Palliative Care"},{"key":"10.1016\/j.biocel.2013.07.016_bib0295","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) \u201ccachexia-anorexia in chronic wasting diseases\u201d and \u201cnutrition in geriatrics\u201d","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clinical Nutrition"},{"key":"10.1016\/j.biocel.2013.07.016_bib0300","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1210\/jc.2003-031768","article-title":"Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial","volume":"89","author":"Neary","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.biocel.2013.07.016_bib0305","first-page":"611","article-title":"Muscle atrophy in cachexia: can dietary protein tip the balance?","volume":"12","author":"Op Den Kamp","year":"2009","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1016\/j.biocel.2013.07.016_bib0310","doi-asserted-by":"crossref","first-page":"e26865","DOI":"10.1371\/journal.pone.0026865","article-title":"Ghrelin and its analogues, BIM-28131 and BIM-28125, improve body weight and regulate the expression of MuRF-1 and MAFbx in a rat heart failure model","volume":"6","author":"Palus","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biocel.2013.07.016_bib0315","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/ijc.25146","article-title":"Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved?","volume":"127","author":"Penna","year":"2010","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.biocel.2013.07.016_bib0320","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/ndt\/gfg203","article-title":"Glucocorticoid antagonist RU38486 fails to block acid-induced muscle wasting in vivo or in vitro","volume":"18","author":"Pickering","year":"2003","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"Suppl. 5","key":"10.1016\/j.biocel.2013.07.016_bib0325","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1038\/sj.ijo.0801911","article-title":"Cytokines and feeding","volume":"25","author":"Plata-Salaman","year":"2001","journal-title":"International Journal of Obesity and Related Metabolic Disorders"},{"key":"10.1016\/j.biocel.2013.07.016_bib0330","doi-asserted-by":"crossref","DOI":"10.1172\/JCI39920","article-title":"Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice","author":"Porporato","year":"2013","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.biocel.2013.07.016_bib0335","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.2527\/jas.2007-0458","article-title":"Interleukin-15: a muscle-derived cytokine regulating fat-to-lean body composition","volume":"86","author":"Quinn","year":"2008","journal-title":"Journal of Animal Science"},{"key":"10.1016\/j.biocel.2013.07.016_bib0340","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/excr.2002.5624","article-title":"Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders","volume":"280","author":"Quinn","year":"2002","journal-title":"Experimental Cell Research"},{"key":"10.1016\/j.biocel.2013.07.016_bib0345","first-page":"427","article-title":"Cancer anorexia-cachexia syndrome: cytokines and neuropeptides","volume":"7","author":"Ramos","year":"2004","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1016\/j.biocel.2013.07.016_bib0350","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1749-6632.1998.tb09560.x","article-title":"Leukemia inhibitory factor regulates proopiomelanocortin transcription","volume":"840","author":"Ray","year":"1998","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.biocel.2013.07.016_bib0355","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1096\/fj.11-189977","article-title":"Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy","volume":"26","author":"Reed","year":"2012","journal-title":"FASEB Journal"},{"key":"10.1016\/j.biocel.2013.07.016_bib0360","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1523\/JNEUROSCI.22-12-05091.2002","article-title":"Involvement of the arcuate nucleus of the hypothalamus in interleukin-1-induced anorexia","volume":"22","author":"Reyes","year":"2002","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.biocel.2013.07.016_bib0365","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1158\/0008-5472.CAN-11-2739","article-title":"Targeting protein synthesis in a Myc\/mTOR-driven model of anorexia-cachexia syndrome delays its onset and prolongs survival","volume":"72","author":"Robert","year":"2012","journal-title":"Cancer Research"},{"key":"10.1016\/j.biocel.2013.07.016_bib0370","first-page":"241","article-title":"Eicosanoid-dependent cancer cachexia and wasting","volume":"5","author":"Ross","year":"2002","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1016\/j.biocel.2013.07.016_bib0375","doi-asserted-by":"crossref","first-page":"E591","DOI":"10.1152\/ajpendo.00073.2004","article-title":"IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1","volume":"287","author":"Sacheck","year":"2004","journal-title":"American Journal of Physiology \u2013 Endocrinology and Metabolism"},{"key":"10.1016\/j.biocel.2013.07.016_bib0380","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2199-8-23","article-title":"Amino acids and insulin act additively to regulate components of the ubiquitin-proteasome pathway in C2C12 myotubes","volume":"8","author":"Sadiq","year":"2007","journal-title":"BMC Molecular Biology"},{"key":"10.1016\/j.biocel.2013.07.016_bib0385","doi-asserted-by":"crossref","first-page":"e29389","DOI":"10.1371\/journal.pone.0029389","article-title":"Leptin reduces the expression and increases the phosphorylation of the negative regulators of GLUT4 traffic TBC1D1 and TBC1D4 in muscle of ob\/ob mice","volume":"7","author":"Sainz","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biocel.2013.07.016_bib0390","first-page":"416","article-title":"Serum levels of adipokines resistin and leptin in patients with colon cancer","volume":"3","author":"Salageanu","year":"2010","journal-title":"Journal of Medicine and Life"},{"key":"10.1016\/j.biocel.2013.07.016_bib0395","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/en.2004-1594","article-title":"Insulin-like growth factor-I gene transfer by electroporation prevents skeletal muscle atrophy in glucocorticoid-treated rats","volume":"146","author":"Schakman","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.biocel.2013.07.016_bib0400","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/17482968.2012.684214","article-title":"Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosis","volume":"13","author":"Shefner","year":"2012","journal-title":"Amyotrophic Lateral Sclerosis"},{"key":"10.1016\/j.biocel.2013.07.016_bib0405","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2310\/JIM.0b013e3181cf91ca","article-title":"Adipokines in patients with cancer anorexia and cachexia","volume":"58","author":"Smiechowska","year":"2010","journal-title":"Journal of Investigative Medicine"},{"key":"10.1016\/j.biocel.2013.07.016_bib0410","doi-asserted-by":"crossref","first-page":"12502","DOI":"10.1073\/pnas.93.22.12502","article-title":"Leukemia inhibitory factor induces differentiation of pituitary corticotroph function: an immuno-neuroendocrine phenotypic switch","volume":"93","author":"Stefana","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.biocel.2013.07.016_bib0415","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s13539-011-0046-2","volume":"2","author":"Stewart Coats","year":"2011","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"key":"10.1016\/j.biocel.2013.07.016_bib0420","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.2174\/138161212803216870","article-title":"Clinical application of ghrelin","volume":"18","author":"Strasser","year":"2012","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.biocel.2013.07.016_bib0425","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.bjc.6604148","article-title":"Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia\/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study","volume":"98","author":"Strasser","year":"2008","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.biocel.2013.07.016_bib0430","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.regpep.2012.06.003","article-title":"Ghrelin improves body weight loss and skeletal muscle catabolism associated with angiotensin II-induced cachexia in mice","volume":"178","author":"Sugiyama","year":"2012","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.biocel.2013.07.016_bib0435","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cmet.2007.09.012","article-title":"Serotonin and the orchestration of energy balance","volume":"6","author":"Tecott","year":"2007","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.biocel.2013.07.016_bib0440","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0167-5273(02)00245-0","article-title":"Cachexia: a therapeutic approach beyond cytokine antagonism","volume":"85","author":"Von Haehling","year":"2002","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.biocel.2013.07.016_bib0445","doi-asserted-by":"crossref","DOI":"10.1007\/s00520-012-1697-z","article-title":"Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients","author":"Wallengren","year":"2013","journal-title":"Supportive Care in Cancer"},{"key":"10.1016\/j.biocel.2013.07.016_bib0450","first-page":"1393","article-title":"Effects of ghrelin on anorexia in tumor-bearing mice with eicosanoid-related cachexia","volume":"28","author":"Wang","year":"2006","journal-title":"International Journal of Oncology"},{"key":"10.1016\/j.biocel.2013.07.016_bib0455","first-page":"500","article-title":"Leptin serum levels in cachectic and non-cachectic lung cancer patients","volume":"77","author":"Werynska","year":"2009","journal-title":"Pneumonologia i Alergologia Polska"},{"key":"10.1016\/j.biocel.2013.07.016_bib0460","doi-asserted-by":"crossref","first-page":"e4774","DOI":"10.1371\/journal.pone.0004774","article-title":"Orally available selective melanocortin-4 receptor antagonists stimulate food intake and reduce cancer-induced cachexia in mice","volume":"4","author":"Weyermann","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biocel.2013.07.016_bib0465","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejphar.2010.11.042","article-title":"Modulation of the central melanocortin system by leptin, insulin, and serotonin: co-ordinated actions in a dispersed neuronal network","volume":"660","author":"Williams","year":"2011","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.biocel.2013.07.016_bib0470","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/cncr.21690","article-title":"Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients","volume":"106","author":"Wolf","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.biocel.2013.07.016_bib0475","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cyto.2012.08.021","article-title":"Human skeletal muscle releases leptin in vivo","volume":"60","author":"Wolsk","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.biocel.2013.07.016_bib0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2011.06248.x","article-title":"Central nervous control of energy and glucose balance: focus on the central melanocortin system","volume":"1243","author":"Xu","year":"2011","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.biocel.2013.07.016_bib0485","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1210\/en.2011-1764","article-title":"Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus","volume":"153","author":"Yoshida","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.biocel.2013.07.016_bib0490","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272513002392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272513002392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:53:22Z","timestamp":1761202402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272513002392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":98,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1357272513002392"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2013.07.016","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Control of food intake and muscle wasting in cachexia","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2013.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}